EUDA Health (EUDA) Competitors

$15.82 +1.20 (+8.21%)

Closing price 04:00 PM Eastern

Extended Trading

$16.03 +0.21 (+1.30%)

As of 07:48 PM Eastern

EUDA vs. NAKA, XGN, PARK, SERA, and DCGO

Should you buy EUDA Health stock or one of its competitors? MarketBeat compares EUDA Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with EUDA Health include KindlyMD (NAKA), Exagen (XGN), Park Dental Partners (PARK), Sera Prognostics (SERA), and DocGo (DCGO). These companies are all part of the "healthcare" industry.

How does EUDA Health compare to KindlyMD?

KindlyMD (NASDAQ:NAKA) and EUDA Health (NASDAQ:EUDA) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, media sentiment, valuation, dividends and profitability.

KindlyMD has a beta of 17.12, meaning that its stock price is 1,612% more volatile than the broader market. Comparatively, EUDA Health has a beta of 0.56, meaning that its stock price is 44% less volatile than the broader market.

EUDA Health has a net margin of 0.00% compared to KindlyMD's net margin of -7,397.12%. EUDA Health's return on equity of 0.00% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KindlyMD	-7,397.12%	-81.32%	-54.17%
EUDA Health	N/A	N/A	N/A

4.4% of EUDA Health shares are held by institutional investors. 24.5% of KindlyMD shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

KindlyMD presently has a consensus price target of $0.75, suggesting a potential upside of 339.37%. EUDA Health has a consensus price target of $55.00, suggesting a potential upside of 247.66%. Given KindlyMD's stronger consensus rating and higher possible upside, equities analysts clearly believe KindlyMD is more favorable than EUDA Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

EUDA Health has higher revenue and earnings than KindlyMD. EUDA Health is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KindlyMD	$1.82M	65.29	-$52.23M	-$1.08	N/A
EUDA Health	$6.82M	5.85	-$2.77M	-$2.40	N/A

In the previous week, KindlyMD had 1 more articles in the media than EUDA Health. MarketBeat recorded 1 mentions for KindlyMD and 0 mentions for EUDA Health. EUDA Health's average media sentiment score of 0.00 beat KindlyMD's score of -0.95 indicating that EUDA Health is being referred to more favorably in the news media.

Company	Overall Sentiment
KindlyMD	Negative
EUDA Health	Neutral

Summary

KindlyMD beats EUDA Health on 9 of the 16 factors compared between the two stocks.

How does EUDA Health compare to Exagen?

EUDA Health (NASDAQ:EUDA) and Exagen (NASDAQ:XGN) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership and profitability.

4.4% of EUDA Health shares are held by institutional investors. Comparatively, 75.3% of Exagen shares are held by institutional investors. 12.6% of Exagen shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

EUDA Health has a beta of 0.56, suggesting that its share price is 44% less volatile than the broader market. Comparatively, Exagen has a beta of 1.81, suggesting that its share price is 81% more volatile than the broader market.

EUDA Health currently has a consensus target price of $55.00, suggesting a potential upside of 247.66%. Exagen has a consensus target price of $9.25, suggesting a potential upside of 147.99%. Given EUDA Health's higher probable upside, analysts clearly believe EUDA Health is more favorable than Exagen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Exagen	1 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.78

EUDA Health has a net margin of 0.00% compared to Exagen's net margin of -29.49%. EUDA Health's return on equity of 0.00% beat Exagen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
EUDA Health	N/A	N/A	N/A
Exagen	-29.49%	-94.37%	-28.96%

EUDA Health has higher earnings, but lower revenue than Exagen. EUDA Health is trading at a lower price-to-earnings ratio than Exagen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EUDA Health	$6.82M	5.85	-$2.77M	-$2.40	N/A
Exagen	$66.57M	1.35	-$19.95M	-$0.89	N/A

In the previous week, Exagen had 4 more articles in the media than EUDA Health. MarketBeat recorded 4 mentions for Exagen and 0 mentions for EUDA Health. Exagen's average media sentiment score of 0.32 beat EUDA Health's score of 0.00 indicating that Exagen is being referred to more favorably in the news media.

Company	Overall Sentiment
EUDA Health	Neutral
Exagen	Neutral

Summary

Exagen beats EUDA Health on 10 of the 16 factors compared between the two stocks.

How does EUDA Health compare to Park Dental Partners?

Park Dental Partners (NASDAQ:PARK) and EUDA Health (NASDAQ:EUDA) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, media sentiment, dividends, earnings, valuation and risk.

In the previous week, Park Dental Partners had 17 more articles in the media than EUDA Health. MarketBeat recorded 17 mentions for Park Dental Partners and 0 mentions for EUDA Health. Park Dental Partners' average media sentiment score of 0.69 beat EUDA Health's score of 0.00 indicating that Park Dental Partners is being referred to more favorably in the media.

Company	Overall Sentiment
Park Dental Partners	Positive
EUDA Health	Neutral

4.4% of EUDA Health shares are owned by institutional investors. 10.6% of Park Dental Partners shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Park Dental Partners has higher revenue and earnings than EUDA Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Park Dental Partners	$244.49M	0.35	N/A	N/A	N/A
EUDA Health	$6.82M	5.85	-$2.77M	-$2.40	N/A

Park Dental Partners currently has a consensus price target of $21.75, indicating a potential upside of 15.75%. EUDA Health has a consensus price target of $55.00, indicating a potential upside of 247.66%. Given EUDA Health's higher probable upside, analysts clearly believe EUDA Health is more favorable than Park Dental Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Park Dental Partners	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	2 Strong Buy rating(s)	2.75
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Net Margins	Return on Equity	Return on Assets
Park Dental Partners	N/A	N/A	N/A
EUDA Health	N/A	N/A	N/A

Summary

Park Dental Partners beats EUDA Health on 6 of the 10 factors compared between the two stocks.

How does EUDA Health compare to Sera Prognostics?

Sera Prognostics (NASDAQ:SERA) and EUDA Health (NASDAQ:EUDA) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, media sentiment, profitability and analyst recommendations.

EUDA Health has higher revenue and earnings than Sera Prognostics. EUDA Health is trading at a lower price-to-earnings ratio than Sera Prognostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sera Prognostics	$80K	851.73	-$31.93M	-$0.65	N/A
EUDA Health	$6.82M	5.85	-$2.77M	-$2.40	N/A

54.6% of Sera Prognostics shares are held by institutional investors. Comparatively, 4.4% of EUDA Health shares are held by institutional investors. 11.3% of Sera Prognostics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Sera Prognostics has a beta of 0.92, suggesting that its stock price is 8% less volatile than the broader market. Comparatively, EUDA Health has a beta of 0.56, suggesting that its stock price is 44% less volatile than the broader market.

EUDA Health has a net margin of 0.00% compared to Sera Prognostics' net margin of -56,385.97%. EUDA Health's return on equity of 0.00% beat Sera Prognostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sera Prognostics	-56,385.97%	-41.02%	-30.95%
EUDA Health	N/A	N/A	N/A

Sera Prognostics presently has a consensus price target of $5.00, suggesting a potential upside of 187.36%. EUDA Health has a consensus price target of $55.00, suggesting a potential upside of 247.66%. Given EUDA Health's higher possible upside, analysts plainly believe EUDA Health is more favorable than Sera Prognostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sera Prognostics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, EUDA Health's average media sentiment score of 0.00 beat Sera Prognostics' score of -1.00 indicating that EUDA Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Sera Prognostics	Negative
EUDA Health	Neutral

Summary

Sera Prognostics and EUDA Health tied by winning 8 of the 16 factors compared between the two stocks.

How does EUDA Health compare to DocGo?

DocGo (NASDAQ:DCGO) and EUDA Health (NASDAQ:EUDA) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, media sentiment, institutional ownership and profitability.

DocGo has a beta of 1.02, indicating that its stock price is 2% more volatile than the broader market. Comparatively, EUDA Health has a beta of 0.56, indicating that its stock price is 44% less volatile than the broader market.

DocGo presently has a consensus price target of $2.38, suggesting a potential upside of 319.17%. EUDA Health has a consensus price target of $55.00, suggesting a potential upside of 247.66%. Given DocGo's stronger consensus rating and higher probable upside, equities analysts plainly believe DocGo is more favorable than EUDA Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DocGo	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

EUDA Health has a net margin of 0.00% compared to DocGo's net margin of -62.23%. EUDA Health's return on equity of 0.00% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DocGo	-62.23%	-44.09%	-29.14%
EUDA Health	N/A	N/A	N/A

56.4% of DocGo shares are held by institutional investors. Comparatively, 4.4% of EUDA Health shares are held by institutional investors. 3.8% of DocGo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, DocGo had 7 more articles in the media than EUDA Health. MarketBeat recorded 7 mentions for DocGo and 0 mentions for EUDA Health. DocGo's average media sentiment score of 0.21 beat EUDA Health's score of 0.00 indicating that DocGo is being referred to more favorably in the media.

Company	Overall Sentiment
DocGo	Neutral
EUDA Health	Neutral

EUDA Health has lower revenue, but higher earnings than DocGo. EUDA Health is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DocGo	$322.20M	0.17	-$182.40M	-$1.91	N/A
EUDA Health	$6.82M	5.85	-$2.77M	-$2.40	N/A

Summary

DocGo beats EUDA Health on 11 of the 16 factors compared between the two stocks.

Get EUDA Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EUDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EUDA vs. The Competition

Export

Metric	EUDA Health	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$36.78M	$1.42B	$6.25B	$12.23B
Dividend Yield	N/A	N/A	2.80%	5.32%
P/E Ratio	-6.59	65.26	20.79	25.05
Price / Sales	5.85	6.01	531.21	72.69
Price / Cash	N/A	22.74	43.09	54.25
Price / Book	-7.00	5.91	9.81	6.83
Net Income	-$2.77M	-$54.76M	$3.55B	$335.69M
7 Day Performance	10.24%	1.19%	-2.07%	-2.03%
1 Month Performance	200.76%	4.84%	-3.90%	-1.90%
1 Year Performance	-79.61%	-7.66%	29.39%	27.36%

EUDA Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EUDA EUDA Health	1.6773 of 5 stars	$15.82 +8.2%	$55.00 +247.7%	-80.9%	$36.78M	$6.82M	N/A	2	Gap Up
NAKA KindlyMD	3.0121 of 5 stars	$0.17 -3.3%	$0.75 +341.7%	N/A	$121.17M	$1.82M	N/A	N/A	Gap Up
XGN Exagen	4.1017 of 5 stars	$3.47 -6.5%	$9.25 +166.6%	-41.9%	$89.63M	$66.57M	N/A	220
PARK Park Dental Partners	2.5234 of 5 stars	$18.30 -3.5%	$21.75 +18.9%	N/A	$85.61M	$244.49M	N/A	1,208	News Coverage Earnings Report Analyst Downgrade Analyst Revision
SERA Sera Prognostics	2.2643 of 5 stars	$1.59 -5.9%	$5.00 +214.5%	-24.2%	$66.15M	$80K	N/A	120	Gap Down High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:EUDA) was last updated on 5/19/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

EUDA Health (EUDA) Competitors

EUDA vs. NAKA, XGN, PARK, SERA, and DCGO

How does EUDA Health compare to KindlyMD?

Summary

How does EUDA Health compare to Exagen?

Summary

How does EUDA Health compare to Park Dental Partners?

Summary

How does EUDA Health compare to Sera Prognostics?

Summary

How does EUDA Health compare to DocGo?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EUDA vs. The Competition

EUDA Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

EUDA Health (EUDA) Competitors

EUDA vs. NAKA, XGN, PARK, SERA, and DCGO

How does EUDA Health compare to KindlyMD?

Which has more volatility & risk, NAKA or EUDA?

Is NAKA or EUDA more profitable?

Do institutionals & insiders hold more shares of NAKA or EUDA?

Do analysts recommend NAKA or EUDA?

Which has better valuation & earnings, NAKA or EUDA?

Does the media prefer NAKA or EUDA?

Summary

How does EUDA Health compare to Exagen?

Do institutionals & insiders have more ownership in EUDA or XGN?

Which has more risk and volatility, EUDA or XGN?

Do analysts rate EUDA or XGN?

Is EUDA or XGN more profitable?

Which has better earnings & valuation, EUDA or XGN?

Does the media refer more to EUDA or XGN?

Summary

How does EUDA Health compare to Park Dental Partners?

Does the media refer more to PARK or EUDA?

Do insiders and institutionals believe in PARK or EUDA?

Which has higher valuation and earnings, PARK or EUDA?

Do analysts recommend PARK or EUDA?

Is PARK or EUDA more profitable?

Summary

How does EUDA Health compare to Sera Prognostics?

Which has higher valuation & earnings, SERA or EUDA?

Do institutionals and insiders believe in SERA or EUDA?

Which has more volatility and risk, SERA or EUDA?

Is SERA or EUDA more profitable?

Do analysts recommend SERA or EUDA?

Does the media refer more to SERA or EUDA?

Summary

How does EUDA Health compare to DocGo?

Which has more risk and volatility, DCGO or EUDA?

Do analysts rate DCGO or EUDA?

Is DCGO or EUDA more profitable?

Do insiders and institutionals have more ownership in DCGO or EUDA?

Does the media prefer DCGO or EUDA?

Which has stronger earnings and valuation, DCGO or EUDA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EUDA vs. The Competition

EUDA Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools